ABL Diagnostics Update Regarding Non-Binding Letter of Intent

ABL Diagnostics S.A. (Euronext: ABLD – ISIN: FR001400AHX6) informs the market that the non-binding Letter of Intent entered into between ProPhase Labs, Inc. and Advanced Biological Laboratories S.A. ( ...

ProPhase Labs Explores Strategic Options for BE-Smart Test

An update from Prophase Labs ( (PRPH) ) is now available.

ProPhase Labs Charts New Financial Course with Strategic Divestment

ProPhase Labs is embarking on a significant financial restructuring, pivoting its strategy to bolster its balance sheet. The company has formally initiated the sale process for its esophageal cancer ...
Business Insider

ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative

Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance Sheet UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” ...
Yahoo Finance

ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative

UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today announced that ...
The Manila Times

Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd

ProPhase Labs, Inc. (OTC: PRPH) ('ProPhase” or the 'Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET.
Seeking Alpha

ProPhase Labs signals $50M net collection target and strategic initiatives as Crown Medical litigation advances

Ted Karkus, Chairman & CEO, opened by emphasizing the critical importance of shareholder voting on the company's proxy, noting, "If you do not vote for our proxy, you are putting our company in harm's ...
Wall Street Journal

ProPhase Puts Covid Testing Unit in Bankruptcy to Collect Insurance Debts

ProPhase Labs has put a diagnostic-testing unit into bankruptcy, a move it has been planning as a way to collect on millions of dollars in accounts receivables from its days processing Covid-19 tests ...
Hosted on MSN

ProPhase Labs Earnings Call: Balancing Optimism and Challenges

Prophase Labs ((PRPH)) has held its Q2 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and ...
Nasdaq

ProPhase Labs Inc. Receives 180-Day Extension from Nasdaq to Regain Bid Price Compliance

ProPhase Labs received a 180-day extension from Nasdaq to meet its $1.00 bid price compliance requirement. ProPhase Labs Inc. announced that it has received a 180-day extension from Nasdaq to meet the ...
Morningstar

ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer | Morningstar

“The ability to run BE-Smart on brush biopsy samples opens the door to much broader clinical use,” said Ted Karkus, CEO at ProPhase Labs. “Many leading molecular diagnostics cannot be used with brush ...